323 related articles for article (PubMed ID: 29661670)
21. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
[TBL] [Abstract][Full Text] [Related]
22. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
23. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.
Dransfield MT; Bourbeau J; Jones PW; Hanania NA; Mahler DA; Vestbo J; Wachtel A; Martinez FJ; Barnhart F; Sanford L; Lettis S; Crim C; Calverley PM
Lancet Respir Med; 2013 May; 1(3):210-23. PubMed ID: 24429127
[TBL] [Abstract][Full Text] [Related]
24. Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis.
Martinez-Garcia MA; Faner R; Oscullo G; de la Rosa D; Soler-Cataluña JJ; Ballester M; Agusti A
Am J Respir Crit Care Med; 2020 May; 201(9):1078-1085. PubMed ID: 31922913
[No Abstract] [Full Text] [Related]
25. Reported pneumonia in patients with COPD: findings from the INSPIRE study.
Calverley PMA; Stockley RA; Seemungal TAR; Hagan G; Willits LR; Riley JH; Wedzicha JA;
Chest; 2011 Mar; 139(3):505-512. PubMed ID: 20576732
[TBL] [Abstract][Full Text] [Related]
26. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD.
Oshagbemi OA; Franssen FME; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Boer A; de Vries F
Pulm Pharmacol Ther; 2020 Feb; 60():101870. PubMed ID: 31785343
[TBL] [Abstract][Full Text] [Related]
28. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
[TBL] [Abstract][Full Text] [Related]
29. Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
Sonnappa S; Martin R; Israel E; Postma D; van Aalderen W; Burden A; Usmani OS; Price DB;
PLoS One; 2017; 12(6):e0178112. PubMed ID: 28617814
[TBL] [Abstract][Full Text] [Related]
30. Hospitalization for chronic obstructive pulmonary disease and pneumonia: association with the dose of inhaled corticosteroids. A nation-wide cohort study of 52 100 outpatients.
Rønn C; Sivapalan P; Eklöf J; Kamstrup P; Biering-Sørensen T; Bonnesen B; Harboe ZB; Browatzki A; Kjærgaard JL; Meyer CN; Jensen TT; Johansson SL; Bendstrup E; Ulrik CS; Stæhr Jensen JU
Clin Microbiol Infect; 2023 Apr; 29(4):523-529. PubMed ID: 36503112
[TBL] [Abstract][Full Text] [Related]
31. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
Morjaria JB; Rigby A; Morice AH
Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
[TBL] [Abstract][Full Text] [Related]
32. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
[TBL] [Abstract][Full Text] [Related]
33. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
Martinez FJ; Calverley PM; Goehring UM; Brose M; Fabbri LM; Rabe KF
Lancet; 2015 Mar; 385(9971):857-66. PubMed ID: 25684586
[TBL] [Abstract][Full Text] [Related]
34. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
[TBL] [Abstract][Full Text] [Related]
35. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
[TBL] [Abstract][Full Text] [Related]
36. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β
Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA
Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019
[TBL] [Abstract][Full Text] [Related]
37. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
[TBL] [Abstract][Full Text] [Related]
38. Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting.
Pleasants RA; Radlowski PA; Davidson HE
Drugs Aging; 2019 Aug; 36(8):733-745. PubMed ID: 31172422
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study.
Kendzerska T; Aaron SD; To T; Licskai C; Stanbrook M; Vozoris NT; Hogan ME; Tan WC; Bourbeau J; Gershon AS
Ann Am Thorac Soc; 2019 Oct; 16(10):1252-1262. PubMed ID: 31298938
[No Abstract] [Full Text] [Related]
40. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]